Partnership Opportunities

  • Innovative Med Concepts is currently developing a proprietary fixed-dose combination, IMC-1, for the treatment of fibromyalgia. We are committed to healthy, fruitful partnerships to help us develop novel, game-changing therapeutic solutions.

    Our model is highly effective; we are a lean organization comprised of world-class advisors, expert consultants, and contractors. This allows us to act swiftly, remain flexible, and most importantly, maintain maximum integrity in all we undertake. At IMC, we believe teaming up with leading academics and strategic industry partners is the most efficient way to develop innovative new therapies.

  • Below are the 3 key principles that simply present our business model to all current and potential partners:

    • Answering the significant unmet need in fibromyalgia
    • Securing proprietary scientific discovery
    • Offering near-term product availability
  • We have potential partnership opportunities in the following areas:

    • Pipeline Development
      • Moving IMC-1 to successful completion of Phase 3 for the treatment of fibromyalgia and developing future indications such as ME/CFS and IBS
      • Future partnership with IMC's 8 other compounds in the pipeline
    • Licensing & commercialization partnerships
    • Collaboration with partners/foundations committed to improving the health of patients with fibromyalgia and related idiopathic disorders

    To inquire about partnership opportunities, please contact: rick@innovativemedconcepts.com.